Gosset Ownership
Private
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Novocuff General Information
Novocuff has developed a vaginally-inserted, adjustable silicone medical device designed to stabilize the cervix, retain amniotic fluid, and extend pregnancy in women at risk for preterm birth due to PPROM or short cervix. The company has completed two feasibility studies—one for short cervix and one for PPROM—and is preparing a multi-center pivotal U.S. clinical trial in early 2025. Early results are promising but full pivotal data are pending.
Contact Information
Primary Industry
Therapeutic Medical Devices
Corporate Office
Not specified directly, but associated with Central California SBDC Network and Fogarty Innovation in Mountain View, CA, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
March of Dimes Innovation Fund (investor/partner)
Novocuff Funding
No funding data available
To view Novocuff's complete valuation and funding history, request access »